Skip to main content
TipRanks
Go Ultimate75% OFF

Origin Therapeutics Holdings, Inc. (ROVA) Ownership - Who Owns Origin Therapeutics Holdings, Inc.?

4 Followers

Origin Therapeutics Holdings, Inc. (ROVA) Ownership Overview

  • 4.02% Insiders
  • 95.98% Public Companies and Individual Investors

The ownership structure of Origin Therapeutics Holdings, Inc. (TSE:ROVA) stock is a mix of institutional, retail, and individual investors. , 4.02% is owned by Insiders, and 95.98% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Apr 14, 2026Raf SouccarC$25,425
Dec 22, 2025Raf SouccarC$25,425
Dec 15, 2025Geoffrey BenicC$40,000

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

TSE:ROVA top shareholders
Holder# of SharesType% HoldingValue
Geoffrey Benic5,810,502Insider2.83%220,799
Raf Souccar2,454,135Insider1.19%93,257

FAQ

What percentage of Origin Therapeutics Holdings, Inc. (TSE:ROVA) stock is held by retail investors?
According to the latest TipRanks data, approximately 95.98% of Origin Therapeutics Holdings, Inc. (TSE:ROVA) stock is held by public companies and individual investors.
Who owns the most shares of Origin Therapeutics Holdings, Inc. (TSE:ROVA)?
Geoffrey Benic owns the most shares of Origin Therapeutics Holdings, Inc. (TSE:ROVA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.